Vitestro has unveiled Aletta, claimed to be the “world's first” Autonomous Robotic Phlebotomy Device (ARPD), designed for ...

Surmodics stock drops 4.76% in premarket trading following news that the FTC will challenge its proposed acquisition by GTCR.

Stereotaxis targets growth with 2025 product milestones, MAGiC Sweep revenue, and EMAGIN 5F innovation, setting the stage for ...

Psycho-biddy horror has a new twist in "The Rule of Jenny Pen," James Ashcroft's terrific follow-up to "Coming Home in the ...

The global IV therapy and vein access devices market is on a trajectory of significant growth, projected to expand from USD 28.7 billion in 2024 to an estimated USD 47.3 billion by 2034. With a ...

The agency is challenging the deal, citing antitrust concerns due to GTCR's existing ownership of Surmodics' rival Biocoat.

A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary brain ...

House Bill 1879 passed unanimously March 4 on a 95-0 vote, according to the chamber's website. State senators will now ...

Reflow Medical, Inc., a leading developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany. This ...

Today, Benzinga's options scanner spotted 11 options trades for Abbott Laboratories. This is not a typical pattern. The ...

Reflow Medical, Inc., which is headquartered in San Clemente, California, announced the opening of its European subsidiary in Land ...

The interventional cardiology devices market was valued at US$ 16.89 billion in 2024 and is projected to reach US$ 30.23 billion by 2033, registering a CAGR of 7.55% during the forecast period ...